Wednesday, May 08, 2013 11:37:41 AM
http://finance.yahoo.com/news/bioelectronics-expands-clinical-research-140000780.html
will be more scientifically rigid, but I haven't heard much on the studies they announced last year either.
They are, of course, hoping that they won't be forced to go the PMA route, but that seems to be the direction the FDA is leaning. There still is the question on whether or not they will be successful in getting it moved into another category altogether, but the FDA doesn't seem to be in a rush to consider that request.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM